October 4, 2023 · STOCK Act disclosure
Senator Thomas R. Carper (Democrat-DE) bought Revance Therapeutics, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on October 4, 2023 and was disclosed on November 2, 2023 (owner: SP). Members of Congress must report such transactions within 45 days under the STOCK Act.
Revance Therapeutics, Inc. - Common Stock